Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

University of the Philippines

Status and phase: Unknown; Phase 2

Conditions: Covid19

Treatments: Drug: Virgin Coconut Oil

Study type: Interventional

Funder types: Other

Identifiers

NCT04849637

UPMREB 2020-306-01

Details and patient eligibility

About

This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)

Full description

This study will be a randomized controlled trial among hospitalized COVID-19 patients, aged 18 years old and above, admitted at the Philippine General hospital. Patients will be grouped into the following:

1. Group receiving standard of care
2. Group receiving standard of care plus virgin coconut oil (15ml, 3x/day for 2 weeks) as adjunctive therapy.

Patients will be observed as regards to primary outcomes such as recovery/resolution of symptoms and duration of hospital stay

Enrollment: 74 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• symptomatic and asymptomatic COVID-19 hospitalized patients
• has laboratory-confirmed illness during the time of recruitment
• able to take food and medicines enterally

Exclusion criteria

• uncontrolled or newly diagnosed diabetes mellitus
• with chronic heart disease
• having elevated lipid profile at baseline (admission)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

74 participants in 2 patient groups

Standard of care plus adjunctive virgin coconut oil supplementation

Experimental group

Description:

Standard of care plus virgin coconut oil

Treatment:

Drug: Virgin Coconut Oil

COVID-19 Standard of care treatment

No Intervention group

Description:

Standard of care